-
Loading metrics
Open Access
Peer-reviewed
Research Article
A Phase I Double Blind, Placebo-Controlled, Randomized Study of a Multigenic HIV-1 Adenovirus Subtype 35 Vector Vaccine in Healthy Uninfected Adults
-
Michael C. Keefer ,
Contributed equally to this work with: Michael C. Keefer, Jill Gilmour
* E-mail: Michael_Keefer@URMC.Rochester.edu
Affiliation University of Rochester School of Medicine and Dentistry, Rochester, New York, United States of America
⨯ -
Jill Gilmour ,
Contributed equally to this work with: Michael C. Keefer, Jill Gilmour
Affiliation IAVI Human Immunology Laboratory, Imperial College, London, United Kingdom
⨯ -
Peter Hayes,
Affiliation IAVI Human Immunology Laboratory, Imperial College, London, United Kingdom
⨯ -
Dilbinder Gill,
Affiliation IAVI Human Immunology Laboratory, Imperial College, London, United Kingdom
⨯ -
Jakub Kopycinski,
Affiliation IAVI Human Immunology Laboratory, Imperial College, London, United Kingdom
⨯ -
Hannah Cheeseman,
Affiliation IAVI Human Immunology Laboratory, Imperial College, London, United Kingdom
⨯ -
Michelle Cashin-Cox,
Affiliation IAVI Human Immunology Laboratory, Imperial College, London, United Kingdom
⨯ -
Marloes Naarding,
Affiliation IAVI Human Immunology Laboratory, Imperial College, London, United Kingdom
⨯ -
Lorna Clark,
Affiliation IAVI Human Immunology Laboratory, Imperial College, London, United Kingdom
⨯ -
Natalia Fernandez,
Affiliation IAVI Human Immunology Laboratory, Imperial College, London, United Kingdom
⨯ -
Catherine A. Bunce,
Affiliation University of Rochester School of Medicine and Dentistry, Rochester, New York, United States of America
⨯ -
Christine M. Hay,
Affiliation University of Rochester School of Medicine and Dentistry, Rochester, New York, United States of America
⨯ -
Sabrina Welsh,
Affiliation International AIDS Vaccine Initiative (IAVI), New York, New York, United States of America
⨯ -
Wendy Komaroff,
Affiliation International AIDS Vaccine Initiative (IAVI), New York, New York, United States of America
⨯ -
Lottie Hachaambwa,
Affiliation University of Rochester School of Medicine and Dentistry, Rochester, New York, United States of America
⨯ -
Tony Tarragona-Fiol,
Affiliation IAVI Human Immunology Laboratory, Imperial College, London, United Kingdom
⨯ -
Eddy Sayeed,
Affiliation International AIDS Vaccine Initiative (IAVI), New York, New York, United States of America
⨯ -
Devika Zachariah,
Affiliation International AIDS Vaccine Initiative (IAVI), New York, New York, United States of America
⨯ -
James Ackland,
Affiliation Global BioSolutions, Melbourne, Victoria, Australia
⨯ -
Kelley Loughran,
Affiliation The EMMES Corporation, Rockville, Maryland, United States of America
⨯ -
Burc Barin,
Affiliation The EMMES Corporation, Rockville, Maryland, United States of America
⨯ -
Emmanuel Cormier,
Affiliation IAVI Human Immunology Laboratory, Imperial College, London, United Kingdom
⨯ -
Josephine H. Cox,
Affiliation IAVI Human Immunology Laboratory, Imperial College, London, United Kingdom
⨯ -
Patricia Fast,
Affiliation International AIDS Vaccine Initiative (IAVI), New York, New York, United States of America
⨯ - [ ... ],
-
Jean-Louis Excler
Affiliation International AIDS Vaccine Initiative (IAVI), New York, New York, United States of America
⨯ - [ view all ]
- [ view less ]
A Phase I Double Blind, Placebo-Controlled, Randomized Study of a Multigenic HIV-1 Adenovirus Subtype 35 Vector Vaccine in Healthy Uninfected Adults
- Michael C. Keefer,
- Jill Gilmour,
- Peter Hayes,
- Dilbinder Gill,
- Jakub Kopycinski,
- Hannah Cheeseman,
- Michelle Cashin-Cox,
- Marloes Naarding,
- Lorna Clark,
- Natalia Fernandez
- Published: August 3, 2012
- https://doi.org/10.1371/journal.pone.0041936